日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

American Epilepsy Society (AES): Written Comments to Norman E. "Ned" Sharpless, MD, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments: Submitted on: July 16, 2019

美国癫痫协会 (AES):致美国食品药品监督管理局 (FDA) 代理局长 Norman E. “Ned” Sharpless 医学博士的书面意见,该FDA隶属于美国卫生与公众服务部 (HHS),案卷编号为 FDA-2019-N-1482,案卷内容为“含有大麻或大麻衍生化合物的产品的科学数据和信息;公开听证会;征求意见”。提交日期:2019 年 7 月 16 日。

Welty, Timothy E; Chapman, Kevin E; Faught, R Edward Jr; Kotloski, Robert J

Interictal epileptiform discharge effects on neuropsychological assessment and epilepsy surgical planning

发作间期癫痫样放电对神经心理学评估和癫痫手术计划的影响

Drane, Daniel L; Ojemann, Jeffrey G; Kim, Michelle S; Gross, Robert E; Miller, John W; Faught, R Edward Jr; Loring, David W